Company Overview and News


Add IPN
to your dashboard

Headline News

3 Things In Biotech You Should Learn Today: September 20, 2017

2017-09-20 seekingalpha
Welcome to another edition of "3 Things In Biotech You Should Learn Today," a daily digest dedicated to helping you keep pace with the fast-moving world of pharmaceutical and biotechnology research. (135-1)

Why Merrimack Pharmaceuticals Stock Is Tanking Today

2017-05-31 fool
Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services.

Geron's Guiding Light

2017-04-06 seekingalpha
Geron's story during Scarlett's tenure is one of steady progress, not in share price, but in its business operations; Scarlett achieves his greatest coup.

The U.S.A. and China Start Talking: Global Week Ahead

2017-04-03 zacks
???The U.S. Institute for Supply Management (ISM) manufacturing Purchasing Managers Index (PMI) is on tap. Closely tracked ISM data will get trader’s attention. A U.S. output expansion has been taking off since last fall. The recovery began well before the U.S. election -- as equity markets and the economy rebounded from a medley of challenges that reached a nadir early in 2016. But, where are we now? Europe’s manufacturing PMI data, also out on Monday, should set a positive tone for equity markets there.

FDA approves Lexicon Pharma's carcinoid syndrome diarrhea drug

2017-02-28 channelnewsasia
REUTERS: The U.S. Food and Drug Administration said on Tuesday it had approved Lexicon Pharmaceuticals Inc's oral drug to treat carcinoid syndrome diarrhea, a condition that develops in patients with gastrointestinal tumors.

Sanofi Nears Agreement to Sell Some Over-the-Counter Drugs to Ipsen: Source - Bloomberg

2017-02-13 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Sanofi nears deal to sell some over-the-counter drugs to Ipsen - Bloomberg

2017-02-13 reuters
Drugmaker Sanofi (SASY.PA) is close to selling some over-the-counter products to Ipsen SA (IPN.PA), in a deal that could be valued at nearly 100 million euros ($106.18 million), Bloomberg reported.

Nikkei at more than 1-month highs as yen weakens on Trump relief

2017-02-13 reuters
TOKYO Feb 13 Japan's Nikkei share average probed more than one-month highs on Monday, cheered by Wall Street breaking records, a weaker yen and relief that talks between U.S. President Donald Trump and Japan's Prime Minister Shinzo Abe yielded no negative surprises.

US issuers rush to sell Formosa bonds before rule change

2017-02-13 reuters
SINGAPORE, Feb 13 (IFR) - Three US blue chips headed to Taiwan's Formosa bond market last week in a rush to lock in flexible funding ahead of changes in local regulations and a potential shake-up in US tax rules.

Morning News Call - India, February 13

2017-02-13 reuters
TOKYO, Feb 13 Japan's Nikkei share average probed more than one-month highs on Monday, cheered by Wall Street breaking records, a weaker yen and relief that talks between U.S. President Donald Trump and Japan's Prime Minister Shinzo Abe yielded no negative surprises.

MIDEAST STOCKS - Factors to watch - Feb 13

2017-02-13 reuters
DUBAI Feb 13 Here are some factors that may affect Middle East stock markets on Monday. Reuters has not verified the press reports and does not vouch for their accuracy.

Sanofi nears deal to sell some over-the-counter drugs to Ipsen: Bloomberg

2017-02-13 channelnewsasia
REUTERS: Drugmaker Sanofi is close to selling some over-the-counter products to Ipsen SA , in a deal that could be valued at nearly 100 million euros (US$106.18 million), Bloomberg reported.

Is Merrimack Pharmaceuticals Worth Stashing in Portfolios?

2017-02-12 fool
Biotech investors can make big profits when clinical-stage biotech stocks net wins from the U.S. Food and Drug Administration, but in the case of Merrimack Pharmaceuticals (NASDAQ:MACK), its stock has been a bust since the FDA approved its pancreatic cancer drug, Onivyde, back in 2015.

Latest Reports on Diffusion and Merrimack as Drug Stocks are Hit by President Trump's Comments

2017-01-12 accesswire
NEW YORK, NY / ACCESSWIRE / January 12, 2017 / Biotech and Healthcare stocks were slammed Wednesday as President Donald Trump made some critical remarks against the industries at his first news conference since the election. The 5 largest losers in the S&P 500 Index were all pharmaceutical or biotech companies in early trading Wednesday. The iShares NASDAQ Biotechnology Index ETF fell by as much as 4 percent before settling to close down 2.

Why Williams Companies Inc (WMB), Fitbit Inc (FIT) and Merrimack Pharmaceuticals Inc (MACK) Are 3 of Today’s Worst Stocks

2017-01-10 investorplace
Although stocks got Tuesday started on a bullish foot, the optimism faded by midday. A measurable gain that pushed the S&P 500 within sight of a new record high withered away as the day wore on, and the index’s close of 2,268.95 was essentially even with Monday’s last trade.